Alliance news

The San Diego company announced that it would abandon the magnetic resonance imaging market because of unfavorable reimbursement conditions, and would restructure its pipeline to focus on the larger market for ultrasound imaging products.

ALLP will stop promoting Imagent GI (perflubron), approved in August 1993 as the company's first product, which is a contrast agent used in MRI. The company will continue to service existing customers, but eventually will phase out the product. ...